Siemens Healthineers unveils highly innovative clinical chemistry and immunoassay system
Siemens Healthineers unveiled the Atellica™ Solution, a highly flexible immunoassay and clinical chemistry solution featuring patented bi-directional magnetic sample-transport technology that is 10 times faster than conventional conveyors. “We engineered the Atellica Solution based on our customers’ needs and extensive research of market trends,” said Franz Walt, President, Laboratory Diagnostics, Siemens Healthineers. “The result is a game-changer that delivers control and simplicity, so our customers can focus on driving better business and clinical outcomes and spend less time managing operations.”
In addition to the speed afforded by the Atellica Magline™ Transport technology, the Atellica Solution offers a multi-camera vision system and intelligent sample routing for independent control over every sample from routines to STATs.
The Atellica Solution provides unprecedented flexibility to adapt to growing testing needs and space constraints. The solution can be used as a stand-alone system, is scalable up to 10 components and can be combined into more than 300 customizable configurations, including L-shaped, U-shaped, and linear formations. It can also be connected to Aptio® Automation for a comprehensive multidisciplinary solution. The system can handle more than 30 sample container types including pediatric and special containers.
Further, the same reagents can be used across configurations and locations, simplifying laboratory operations, streamlining inventory control, and enabling consistent testing results. Additionally, a single immunoassay analyser processes more than 400 tests per hour, delivering the highest productivity per square meter in the industry.
Other benefits of the Atellica Solution include remote-access monitoring and control to maximize uptime, and a broad, expanding assay menu using proven detection technologies.
The Atellica Solution is the first in a new line of Atellica products.
The products are under FDA review, and not available for sale at this point.
